Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fillat

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Gene Therapy|August 20, 2010
E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer modelsL Garcia-Rodríguez, D Abate-Daga, A Rojas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 1994
Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterationsA Valera, C Fillat, C Costa, et al.
Diabetes|October 1, 1991
Activation by vanadate of glycolysis in hepatocytes from diabetic ratsJ E Rodríguez-Gil, A M Gómez-Foix, C Fillat, et al.
Journal of Neural Transmission. Supplementum|February 10, 2000
Application of Alu-splice PCR on chromosome 21: DSCR1 and IntersectinJ J Fuentes, M Dierssen, C Pucharcós, et al.
Gene Therapy|August 24, 2007
GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour modelA Cascante, D Abate-Daga, L Garcia-Rodríguez, et al.
The Biochemical Journal|October 15, 1988
Vanadate raises fructose 2,6-bisphosphate concentrations and activates glycolysis in rat hepatocytesA M Gómez-Foix, J E Rodríguez-Gil, C Fillat, et al.
Gene Therapy|September 7, 1999
Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase geneM Carrió, A Romagosa, E Mercadé, et al.
Pharmacology, Biochemistry, and Behavior|June 22, 2002
Neurobehavioral development of two mouse lines commonly used in transgenic studiesM Dierssen, V Fotaki, M Martínez de Lagrán, et al.
Gene Therapy|June 20, 2014
iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacyC Puig-Saus, L A Rojas, E Laborda, et al.
The Journal of Clinical Investigation|July 15, 1996
Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapyC Fillat, C M Simonaro, P L Yeyati, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Gene Therapy|August 20, 2010
E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer modelsL Garcia-Rodríguez, D Abate-Daga, A Rojas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 1994
Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterationsA Valera, C Fillat, C Costa, et al.
Diabetes|October 1, 1991
Activation by vanadate of glycolysis in hepatocytes from diabetic ratsJ E Rodríguez-Gil, A M Gómez-Foix, C Fillat, et al.
Journal of Neural Transmission. Supplementum|February 10, 2000
Application of Alu-splice PCR on chromosome 21: DSCR1 and IntersectinJ J Fuentes, M Dierssen, C Pucharcós, et al.
Gene Therapy|August 24, 2007
GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour modelA Cascante, D Abate-Daga, L Garcia-Rodríguez, et al.
The Biochemical Journal|October 15, 1988
Vanadate raises fructose 2,6-bisphosphate concentrations and activates glycolysis in rat hepatocytesA M Gómez-Foix, J E Rodríguez-Gil, C Fillat, et al.
Gene Therapy|September 7, 1999
Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase geneM Carrió, A Romagosa, E Mercadé, et al.
Pharmacology, Biochemistry, and Behavior|June 22, 2002
Neurobehavioral development of two mouse lines commonly used in transgenic studiesM Dierssen, V Fotaki, M Martínez de Lagrán, et al.
Gene Therapy|June 20, 2014
iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacyC Puig-Saus, L A Rojas, E Laborda, et al.
The Journal of Clinical Investigation|July 15, 1996
Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapyC Fillat, C M Simonaro, P L Yeyati, et al.
Pageof 4